Re: Consider buying ALB - too much hype over nuttin (Dawg)
Biggest thing for AMRN is they have a very successful REDUCE-IT trial and have patent protection for quite a while. The biggest boost will be in 2020 when Medicare takes bidding for this type of ailment. It is year by year contract.
I plan on dumping half of my shares in the next week or two. Saturday is the AHA conference